Association of the combined triglyceride glucose-body mass index and serum IQGAP3 in appraising coronary lesion severity in type 2 diabetes - Scorecard - MDSpire
Advertisement
Association of the combined triglyceride glucose-body mass index and serum IQGAP3 in appraising coronary lesion severity in type 2 diabetes
Clinical Scorecard: Evaluating the Relationship Between Serum IQGAP3 Levels, Triglyceride Glucose-Body Mass Index, and Coronary Lesion Severity in Patients with Type 2 Diabetes
At a Glance
Category
Detail
Condition
Type 2 Diabetes Mellitus (T2DM)
Key Mechanisms
Serum IQGAP3 and triglyceride glucose-body mass index (TyG-BMI) are associated with coronary lesion severity.
Target Population
Patients with Type 2 Diabetes Mellitus undergoing coronary angiography.
Care Setting
Cardiology department in a hospital setting.
Key Highlights
Serum IQGAP3 and TyG-BMI are independently associated with severe coronary stenosis.
Combining TyG-BMI with IQGAP3 improves discrimination for coronary lesion severity.
Age modifies the association between IQGAP3 and severe coronary stenosis.
Guideline-Based Recommendations
Diagnosis
Use serum IQGAP3 levels and TyG-BMI for assessing coronary lesion severity.
Management
Consider integrating IQGAP3 and TyG-BMI in cardiovascular risk stratification.
Monitoring & Follow-up
Monitor serum IQGAP3 and TyG-BMI levels in patients with T2DM.
Risks
Invasive coronary angiography carries risks such as contrast-induced injury.
Patient & Prescribing Data
Adults with Type 2 Diabetes Mellitus undergoing coronary angiography.
Assessment of IQGAP3 and TyG-BMI may guide therapeutic strategies.
Clinical Best Practices
Utilize non-invasive biomarkers for early risk stratification in T2DM patients.
Incorporate metabolic and inflammatory markers in cardiovascular assessments.
Narrative review describes how physiologic stressors accumulate from induction through postintubation care and may contribute to cardiovascular deterioration during airway management.
